Details for New Drug Application (NDA): 020491
✉ Email this page to a colleague
The generic ingredient in CORVERT is ibutilide fumarate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.
Summary for 020491
Tradename: | CORVERT |
Applicant: | Pfizer |
Ingredient: | ibutilide fumarate |
Patents: | 0 |
Suppliers and Packaging for NDA: 020491
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CORVERT | ibutilide fumarate | INJECTABLE;INJECTION | 020491 | NDA | Pharmacia & Upjohn Company LLC | 0009-3794 | 0009-3794-22 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-3794-22) / 10 mL in 1 VIAL, SINGLE-DOSE |
CORVERT | ibutilide fumarate | INJECTABLE;INJECTION | 020491 | NDA | Pharmacia & Upjohn Company LLC | 0009-3794 | 0009-3794-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-3794-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.1MG/ML | ||||
Approval Date: | Dec 28, 1995 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 020491
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CORVERT | ibutilide fumarate | INJECTABLE;INJECTION | 020491-001 | Dec 28, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription